ReFocus Eye Health Acquires Soll Eye, Adding Four Northeast Practice Locations

More Images
RYE BROOK, N.Y.—ReFocus Eye Health, a collaborative organization that says it brings a fresh approach to practice ownership and management, has acquired Soll Eye, according to an announcement this week. The terms of the deal, which was effective “immediately,” were not disclosed. The acquisition brings all four Soll Eye locations across Pennsylvania and New Jersey to the ReFocus Eye Health family, as well as Soll Eye's team of doctors and staff. "I am thrilled to share the news that Soll Eye has partnered with ReFocus," founder Dr. Stephen Soll said in the announcement. "My team and I will have greater access to cutting-edge technology and other resources to better serve our patients and community at all Soll Eye locations."

Two of the practice’s four locations are in Philadelphia, one in Camden, N.J., and the fourth is in Penndel, Pa.

Upon closing of the deal, ReFocus Eye Health now has three eyecare practices with eight locations across Connecticut, New Jersey and Pennsylvania within its organization, a spokeswoman told VMAIL.

With more than 60 years of experience serving patients, Soll Eye is one of the top eye health providers in the Northeast. Its team of seven doctors are among the most nationally recognized leaders in their clinical fields, delivering a spectrum of vision services ranging from primary eyecare, cataract surgery, vitreo-retinal procedures and other treatments. Its optical center carries dozens of leading brands, with custom fitting, specialty glasses, and more, the announcement noted.

Dan Doman, chief executive officer of ReFocus Eye Health, said that the firm’s goal is to provide the strategy, innovation and support that brings better eyecare to people. "Our acquisition of Soll Eye helps us further build on this mission, while lending the power of our expertise and resources to the talented doctors and team at its locations," he added.

“This partnership establishes an important foothold for ReFocus in the Pennsylvania and New Jersey markets," added Sean Hayes, a partner at investment firm Zenyth Partners, which lists ReFocus as one of its portfolio companies. "We look forward to working with Dr. Soll and his team to extend our footprint while continuing to deliver exceptional eyecare to our patients."

ReFocus Eye Health, which was founded in 2018, has built a group of connected ophthalmology and optometry practices that are committed to providing the highest level of care, with top-quality medical expertise, advanced technology and business management. As a source of permanent capital, ReFocus invests in these ophthalmology and optometric practices exclusively for long-term growth.

Its experienced team of investment professionals, business builders, and clinicians work alongside local physicians to transform the total eyecare experience for patients through the use of clinical and management best practices, according to this week’s announcement.